A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy

BACKGROUND: Lung cancer is one of the most frequent malignancies in humans and is a major cause of death. A number of therapies aimed at reinforcing antitumor immune response, including antiprogrammed cell death protein 1 (anti-PD-1) antibodies, are successfully used to treat several neoplasias as n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Alonso, Santiago, Setti-Jerez, Giulia, Arroyo, Montserrat, Hernández, Tathiana, Martos, Mª Inmaculada, Sánchez-Torres, Jose Miguel, Colomer, Ramon, Ramiro, Almudena R, Alfranca, Arantzazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478024/
https://www.ncbi.nlm.nih.gov/pubmed/32900863
http://dx.doi.org/10.1136/jitc-2020-001187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478024/
https://www.ncbi.nlm.nih.gov/pubmed/32900863
http://dx.doi.org/10.1136/jitc-2020-001187

Ejemplares similares